Difference between revisions of "EGF Receptor"
m |
m |
||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 47: | Line 47: | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:33, 10 March 2015
| EGF Receptor | |
|---|---|
| Substrate peptide name | EGF Receptor |
| Synonyms | EGFR |
| Determination type | In situ |
| Source | Rattus norvegicus |
| Subcellular localization | Plasma membrane |
| Swissprot ID | Q01279 |
| Reactive glutamines | Not determined yet |
| Reactive lysines | Not determined yet |
| Substrate sequence | Not determined yet |
| Structure | |
| Surface accessibility | |
| Disorder prediction | |
| Reference | PMID:19614676 |
| Notes | Transglutaminase down-regulates the dimerization and subsequent
autophosphorylation of epidermal growth factor receptor in rat periportal and perivenous hepatocytes. |
